Clinical Trials Directory

Trials / Conditions / Rifampicin Resistant Tuberculosis

Rifampicin Resistant Tuberculosis

11 registered clinical trials studyying Rifampicin Resistant Tuberculosis — 6 currently recruiting.

StatusTrialSponsorPhase
Not Yet RecruitingAcetohydroxamic Acid Combined With a Short-Course Regimen for MDR-TB (AHA-PLUS)
NCT07393438
Shanghai Pulmonary Hospital, Shanghai, ChinaPhase 2
Not Yet RecruitingInnovating Shorter, All- Oral, Precised Treatment Regimen for Rifampicin Resistant Tuberculosis：BLMZ Chinese C
NCT07268664
Beijing Chest HospitalPhase 3
RecruitingA Phase 2b Clinical Study of JDB0131 Benzenesulfonate Tablets
NCT07170800
WestVac Biopharma Co., Ltd.Phase 2
Not Yet RecruitingFrench National Cohort of Patients With Rifampicin-Resistant Tuberculosis
NCT06565806
Assistance Publique - Hôpitaux de Paris—
Active Not RecruitingInnovating Shorter, All- Oral, Precised, Individualized Treatment Regimen for Rifampicin Resistant Tuberculosi
NCT06081361
Beijing Chest HospitalPhase 3
RecruitingStudy of a Single Dose of Pretomanid Added to an Optimized Background Regimen in Children With Rifampicin-Resi
NCT05586230
National Institute of Allergy and Infectious Diseases (NIAID)Phase 1
RecruitingInnovating(IN) Shorter(S), All- Oral, Precised(P), Individualized(I) Treatment Regimen(RE) for Rifampicin Resi
NCT05081401
Huashan HospitalPhase 3
UnknownSequencing Mycobacteria and Algorithm-determined Resistant Tuberculosis Treatment Trial
NCT05017324
Universiteit AntwerpenN/A
CompletedBuilding Evidence for Advancing New Treatment for Rifampicin Resistant Tuberculosis (RR-TB) Comparing a Short
NCT04062201
Wits Health Consortium (Pty) LtdPhase 3
CompletedGeneXpert Performance Evaluation for Linkage to Tuberculosis Care
NCT03044158
University of California, San FranciscoN/A
CompletedLine Probe Assay Evaluation Study
NCT02984579
Foundation for Innovative New Diagnostics, Switzerland—